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The title compound, C18H20ClN3S, is a functionalized triazo-
line-3-thione derivative. The benzene ring is almost perpendic-
ular to the planar 1,2,4-triazole ring [maximum deviation =
0.007 (1) A˚] with a dihedral angle of 89.61 (5) between them
and there is an adamantane substituent at the 3-position of the
triazolethione ring. In the crystal, N—H  S hydrogen-
bonding interactions link the molecules into chains extending
along the c-axis direction. The crystal packing is further
stabilized by weak C—H   interactions that link adjacent
chains into a two-dimensional structure in the bc plane. The
crystal studied was an inversion twin with a 0.50 (3):0.50 (3)
domain ratio.




For the biological activity of adamantane derivatives, see:
Lorenzo et al. (2008); Wang et al. (2013); Kadi et al. (2010);
Balzarini et al. (2009); Protopopova et al. (2005); Vernier et al.
(1969). For the biological activity of adamantyl-1,2,4-triazole
derivatives, see: El-Emam & Ibrahim (1991); Al-Abdullah et
al. (2014); El-Emam et al. (2004, 2013). For related adamantyl-
1,2,4-triazole structures, see: El-Emam et al. (2012), Al-
Tamimi et al. (2013), Al-Omary et al. (2014); Almutairi et al.







a = 23.1302 (5) A˚
c = 6.4100 (2) A˚
V = 3429.39 (18) A˚3
Z = 8
Mo K radiation
 = 0.35 mm1
T = 150 K






10584 reflections with I > 2(I)
Rint = 0.033
2.3. Refinement
R[F 2 > 2(F 2)] = 0.030




H atoms treated by a mixture of
independent and constrained
refinement
max = 0.53 e A˚
3
min = 0.31 e A˚3





Hydrogen-bond geometry (A˚, ).
Cg2 is the centroid of the C1–C6 phenyl ring.
D—H  A D—H H  A D  A D—H  A
N3—H1N3  S1i 0.92 (2) 2.46 (2) 3.3253 (9) 158.4 (19)
C13—H13A  Cg2ii 0.98 2.97 3.8881 (13) 156
Symmetry codes: (i) xþ 12;yþ 32; z 12; (ii) y  1;xþ 1;zþ 1.
Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT
(Bruker, 2009); data reduction: SAINT; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine
structure: SHELXL2013 (Sheldrick, 2015); molecular graphics:
SHELXTL (Sheldrick, 2008); software used to prepare material for
publication: SHELXTL and PLATON (Spek, 2009).
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Crystal structure of 3-(adamantan-1-yl)-4-(4-chlorophenyl)-1H-1,2,4-
triazole-5(4H)-thione
Reem I. Al-Wabli, Ali A. El-Emam, Obaid S. Alroqi, C. S. Chidan Kumar and Hoong-Kun Fun
S1. Chemical context 
Adamantane derivatives have long been known for their diverse biological activities (Wang et al., 2013) including anti-
viral activity against influenza (Vernier et al., 1969) and HIV viruses (El-Emam et al., 2004; Balzarini et al., 2009). In 
addition, adamantane derivatives are known to exhibit marked antibacterial activity (Kadi et al., 2010; Protopopova et al., 
2005). In an earlier publication, we reported the synthesis and potent antimicrobial and anti-inflammatory activities of the 
title compound and its related derivatives (Al-Deeb et al., 2006). 
S2. Structural commentary 
In the title compound (Fig. 1), the 1,2,4-triazole (N1—N3/C7/C8) ring is nearly planar with a maximum deviation of 
-0.007 (1) Å at atom N1. The phenyl (C1–C6) ring is almost perpendicular to the near planar 1,2,4-triazole ring with a 
dihedral angle of 89.61 (5) Å between them. An adamantane group is substituted at the 3-position of the triazolethione 
ring. The crystal studied was an inversion twin with a 0.50 (3):0.50 (3) domain ratio. 
S3. Supramolecular features 
In the crystal packing (Fig. 2), the molecules are linked by intermolecular N3–H1N3···S1 hydrogen bonding interactions 
forming chains extending along along the c axis direction. The crystal packing is further stabilized by weak C–H···π 
(phenyl) interactions (Table 1) that link the adjacent chains into a two dimensional structure in the bc plane. 
S4. Synthesis and crystallization 
The title compound was prepared by a literature procedure (Al-Deeb et al., 2006) and crystallized from EtOH/CHCl3 
(1:1) to yield colorless crystals. M·P.: >300 °C.
1H NMR (CDCl3, 700.17 MHz): δ 1.55-1.70 (m, 6H, Adamantane-H), 1.86-2.05 (m, 9H, Adamantane-H), 7.25 (d, 2H, 
Ar—H, J = 8.5 Hz), 7.45 (d, 2H, Ar—H, J = 8.5 Hz), 11.90 (br. s, 1H, NH). 13C NMR (CDCl3, 176.08 MHz): δ 27.68, 
36.03, 36.44, 39.80 (Adamantane-C), 129.95, 131.02, 134.23, 136.42 (Ar—C), 158.41 (C=N), 170.0 (C=S). 
S5. Refinement details 
The nitrogen-bound H-atom was located in a difference Fourier map and its coordinates and isotropic displacement 
parameter were refined freely with d(N–H) = 0.92 (2) Å. Other H atoms were positioned geometrically (d(C–H) 0.93–
0.98 Å) and refined using a riding model with Uiso(H) = 1.2 Ueq(C). The crystal studied was an inversion twin with a 0.50 
(3):0.50 (3) domain ratio. 
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Figure 1
The molecular structure of the title compound with atom labels and 50% probability displacement ellipsoids. 
supporting information
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Figure 2
Crystal packing of the title compound, showing the N–H···S hydrogen bonding interactions (Table 1) as dashed lines 






a = 23.1302 (5) Å
c = 6.4100 (2) Å
V = 3429.39 (18) Å3
Z = 8
F(000) = 1456
Dx = 1.340 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 9155 reflections
θ = 2.5–40.8°
µ = 0.35 mm−1
T = 150 K
Needle, colourless
0.68 × 0.29 × 0.26 mm
Data collection 
Bruker APEXII CCD 
diffractometer
φ and ω scans
106262 measured reflections
11408 independent reflections
10584 reflections with I > 2σ(I)
Rint = 0.033















Hydrogen site location: mixed
H atoms treated by a mixture of independent 
and constrained refinement
w = 1/[σ2(Fo2) + (0.0483P)2 + 0.551P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max = 0.002
Δρmax = 0.53 e Å−3
Δρmin = −0.31 e Å−3
Absolute structure: Flack (1983), 5353 Friedel 
pairs
Absolute structure parameter: 0.50 (3)
Special details 
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refined as a 2-component inversion twin.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
S1 0.25120 (2) 0.81338 (2) 0.20570 (4) 0.01558 (4)
Cl1 0.10286 (2) 0.98207 (2) 0.89359 (5) 0.03118 (7)
N1 0.15119 (3) 0.77326 (3) 0.38819 (12) 0.01309 (10)
N2 0.13872 (4) 0.68822 (4) 0.23712 (14) 0.01734 (13)
N3 0.18691 (3) 0.71564 (4) 0.16208 (13) 0.01642 (12)
C1 0.16658 (4) 0.83033 (4) 0.70574 (15) 0.01686 (13)
H1A 0.1901 0.8012 0.7588 0.020*
C2 0.15555 (5) 0.87980 (4) 0.82355 (16) 0.01990 (15)
H2A 0.1715 0.8840 0.9558 0.024*
C3 0.12041 (5) 0.92258 (4) 0.74046 (17) 0.01972 (15)
C4 0.09818 (5) 0.91871 (4) 0.53962 (19) 0.02225 (17)
H4A 0.0761 0.9486 0.4843 0.027*
C5 0.10952 (4) 0.86925 (4) 0.42249 (16) 0.01916 (15)
H5A 0.0953 0.8660 0.2874 0.023*
C6 0.14220 (4) 0.82486 (4) 0.50837 (14) 0.01374 (12)
C7 0.19637 (3) 0.76715 (4) 0.25068 (13) 0.01323 (12)
C8 0.11738 (4) 0.72353 (4) 0.37613 (14) 0.01404 (12)
C9 0.06417 (3) 0.70942 (4) 0.50180 (14) 0.01456 (12)
C10 0.04492 (5) 0.64750 (5) 0.4465 (2) 0.02441 (19)
H10A 0.0368 0.6450 0.2983 0.029*
H10B 0.0758 0.6206 0.4784 0.029*
C11 −0.00943 (6) 0.63104 (5) 0.5707 (2) 0.0292 (2)
H11A −0.0214 0.5918 0.5330 0.035*
C12 −0.05832 (5) 0.67338 (6) 0.5199 (2) 0.0292 (2)
H12A −0.0673 0.6716 0.3722 0.035*
H12B −0.0928 0.6628 0.5971 0.035*
C13 −0.03997 (4) 0.73459 (6) 0.5782 (2) 0.02497 (19)
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H13A −0.0715 0.7615 0.5465 0.030*
C14 −0.02609 (5) 0.73732 (7) 0.8112 (2) 0.0307 (2)
H14A −0.0145 0.7763 0.8487 0.037*
H14B −0.0602 0.7274 0.8916 0.037*
C15 0.02267 (5) 0.69501 (7) 0.86116 (18) 0.0303 (3)
H15A 0.0313 0.6967 1.0107 0.036*
C16 0.07706 (4) 0.71160 (6) 0.73728 (16) 0.0253 (2)
H16A 0.1082 0.6850 0.7703 0.030*
H16B 0.0893 0.7503 0.7759 0.030*
C17 0.00415 (6) 0.63344 (7) 0.8040 (3) 0.0356 (3)
H17A 0.0349 0.6065 0.8369 0.043*
H17B −0.0298 0.6226 0.8838 0.043*
C18 0.01416 (4) 0.75172 (5) 0.45273 (18) 0.02095 (16)
H18A 0.0256 0.7908 0.4888 0.025*
H18B 0.0055 0.7507 0.3047 0.025*
H1N3 0.2084 (9) 0.6995 (9) 0.057 (4) 0.029 (5)*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
S1 0.01413 (8) 0.01610 (8) 0.01653 (8) −0.00195 (6) 0.00022 (6) 0.00131 (6)
Cl1 0.04393 (16) 0.01649 (9) 0.03312 (14) 0.00301 (9) 0.01278 (12) −0.00681 (9)
N1 0.0119 (2) 0.0135 (2) 0.0139 (3) 0.00076 (19) 0.0009 (2) −0.0017 (2)
N2 0.0145 (3) 0.0176 (3) 0.0200 (3) −0.0026 (2) 0.0042 (2) −0.0047 (2)
N3 0.0140 (3) 0.0175 (3) 0.0178 (3) −0.0019 (2) 0.0040 (2) −0.0052 (2)
C1 0.0189 (3) 0.0158 (3) 0.0158 (3) 0.0034 (2) −0.0032 (3) −0.0026 (3)
C2 0.0251 (4) 0.0178 (3) 0.0168 (4) 0.0013 (3) −0.0005 (3) −0.0038 (3)
C3 0.0226 (4) 0.0136 (3) 0.0230 (4) 0.0011 (3) 0.0052 (3) −0.0030 (3)
C4 0.0248 (4) 0.0151 (3) 0.0269 (5) 0.0065 (3) −0.0008 (3) 0.0000 (3)
C5 0.0211 (4) 0.0170 (3) 0.0193 (4) 0.0048 (3) −0.0030 (3) 0.0002 (3)
C6 0.0133 (3) 0.0127 (3) 0.0152 (3) 0.0021 (2) 0.0000 (2) −0.0015 (2)
C7 0.0117 (3) 0.0146 (3) 0.0134 (3) 0.0007 (2) 0.0000 (2) −0.0005 (2)
C8 0.0120 (3) 0.0152 (3) 0.0149 (3) 0.0001 (2) 0.0010 (2) −0.0016 (2)
C9 0.0113 (3) 0.0177 (3) 0.0146 (3) −0.0002 (2) 0.0011 (2) 0.0002 (3)
C10 0.0227 (4) 0.0184 (4) 0.0322 (5) −0.0046 (3) 0.0090 (4) −0.0016 (3)
C11 0.0251 (5) 0.0242 (4) 0.0382 (6) −0.0082 (4) 0.0103 (4) 0.0016 (4)
C12 0.0150 (4) 0.0438 (6) 0.0288 (5) −0.0089 (4) −0.0016 (3) 0.0016 (5)
C13 0.0125 (3) 0.0319 (5) 0.0305 (5) 0.0038 (3) 0.0031 (3) 0.0058 (4)
C14 0.0208 (4) 0.0435 (7) 0.0280 (5) −0.0009 (4) 0.0101 (4) −0.0069 (5)
C15 0.0181 (4) 0.0568 (8) 0.0161 (4) −0.0046 (4) 0.0023 (3) 0.0064 (4)
C16 0.0140 (3) 0.0462 (6) 0.0157 (4) −0.0035 (4) −0.0010 (3) 0.0036 (4)
C17 0.0241 (5) 0.0438 (7) 0.0388 (7) 0.0009 (5) 0.0085 (5) 0.0235 (6)
C18 0.0134 (3) 0.0238 (4) 0.0256 (4) 0.0034 (3) 0.0018 (3) 0.0055 (3)
Geometric parameters (Å, º) 
S1—C7 1.6836 (9) C10—H10A 0.9700
Cl1—C3 1.7384 (10) C10—H10B 0.9700
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N1—C7 1.3744 (11) C11—C17 1.529 (2)
N1—C8 1.3931 (11) C11—C12 1.531 (2)
N1—C6 1.4355 (11) C11—H11A 0.9800
N2—C8 1.3056 (12) C12—C13 1.5246 (19)
N2—N3 1.3696 (11) C12—H12A 0.9700
N3—C7 1.3379 (12) C12—H12B 0.9700
N3—H1N3 0.92 (2) C13—C14 1.529 (2)
C1—C6 1.3909 (13) C13—C18 1.5399 (15)
C1—C2 1.3946 (13) C13—H13A 0.9800
C1—H1A 0.9300 C14—C15 1.527 (2)
C2—C3 1.3869 (14) C14—H14A 0.9700
C2—H2A 0.9300 C14—H14B 0.9700
C3—C4 1.3892 (16) C15—C17 1.532 (2)
C4—C5 1.3933 (14) C15—C16 1.5362 (15)
C4—H4A 0.9300 C15—H15A 0.9800
C5—C6 1.3889 (12) C16—H16A 0.9700
C5—H5A 0.9300 C16—H16B 0.9700
C8—C9 1.5067 (12) C17—H17A 0.9700
C9—C16 1.5394 (14) C17—H17B 0.9700
C9—C10 1.5413 (14) C18—H18A 0.9700
C9—C18 1.5473 (13) C18—H18B 0.9700
C10—C11 1.5359 (15)
C7—N1—C8 107.83 (7) C17—C11—H11A 109.4
C7—N1—C6 122.67 (7) C12—C11—H11A 109.4
C8—N1—C6 129.42 (7) C10—C11—H11A 109.4
C8—N2—N3 104.93 (7) C13—C12—C11 109.64 (9)
C7—N3—N2 113.35 (7) C13—C12—H12A 109.7
C7—N3—H1N3 125.9 (14) C11—C12—H12A 109.7
N2—N3—H1N3 120.7 (14) C13—C12—H12B 109.7
C6—C1—C2 119.54 (8) C11—C12—H12B 109.7
C6—C1—H1A 120.2 H12A—C12—H12B 108.2
C2—C1—H1A 120.2 C12—C13—C14 109.65 (11)
C3—C2—C1 118.99 (9) C12—C13—C18 109.72 (10)
C3—C2—H2A 120.5 C14—C13—C18 109.20 (9)
C1—C2—H2A 120.5 C12—C13—H13A 109.4
C2—C3—C4 121.80 (9) C14—C13—H13A 109.4
C2—C3—Cl1 119.00 (8) C18—C13—H13A 109.4
C4—C3—Cl1 119.20 (8) C15—C14—C13 109.46 (10)
C3—C4—C5 118.85 (9) C15—C14—H14A 109.8
C3—C4—H4A 120.6 C13—C14—H14A 109.8
C5—C4—H4A 120.6 C15—C14—H14B 109.8
C6—C5—C4 119.73 (9) C13—C14—H14B 109.8
C6—C5—H5A 120.1 H14A—C14—H14B 108.2
C4—C5—H5A 120.1 C14—C15—C17 109.82 (10)
C5—C6—C1 120.93 (8) C14—C15—C16 109.66 (11)
C5—C6—N1 118.74 (8) C17—C15—C16 109.74 (11)
C1—C6—N1 120.33 (7) C14—C15—H15A 109.2
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N3—C7—N1 103.86 (7) C17—C15—H15A 109.2
N3—C7—S1 128.03 (7) C16—C15—H15A 109.2
N1—C7—S1 128.11 (7) C15—C16—C9 109.88 (8)
N2—C8—N1 110.01 (8) C15—C16—H16A 109.7
N2—C8—C9 122.57 (8) C9—C16—H16A 109.7
N1—C8—C9 127.42 (8) C15—C16—H16B 109.7
C8—C9—C16 111.04 (7) C9—C16—H16B 109.7
C8—C9—C10 108.32 (7) H16A—C16—H16B 108.2
C16—C9—C10 108.17 (9) C11—C17—C15 108.97 (10)
C8—C9—C18 111.41 (8) C11—C17—H17A 109.9
C16—C9—C18 108.87 (8) C15—C17—H17A 109.9
C10—C9—C18 108.96 (8) C11—C17—H17B 109.9
C11—C10—C9 110.34 (9) C15—C17—H17B 109.9
C11—C10—H10A 109.6 H17A—C17—H17B 108.3
C9—C10—H10A 109.6 C13—C18—C9 109.81 (8)
C11—C10—H10B 109.6 C13—C18—H18A 109.7
C9—C10—H10B 109.6 C9—C18—H18A 109.7
H10A—C10—H10B 108.1 C13—C18—H18B 109.7
C17—C11—C12 109.66 (11) C9—C18—H18B 109.7
C17—C11—C10 109.25 (11) H18A—C18—H18B 108.2
C12—C11—C10 109.63 (10)
C8—N2—N3—C7 0.12 (11) N1—C8—C9—C10 −175.22 (9)
C6—C1—C2—C3 −0.08 (15) N2—C8—C9—C18 −115.92 (10)
C1—C2—C3—C4 −3.09 (16) N1—C8—C9—C18 64.95 (12)
C1—C2—C3—Cl1 175.90 (8) C8—C9—C10—C11 −179.89 (10)
C2—C3—C4—C5 2.89 (17) C16—C9—C10—C11 59.67 (12)
Cl1—C3—C4—C5 −176.10 (9) C18—C9—C10—C11 −58.54 (13)
C3—C4—C5—C6 0.48 (16) C9—C10—C11—C17 −60.75 (14)
C4—C5—C6—C1 −3.62 (15) C9—C10—C11—C12 59.44 (14)
C4—C5—C6—N1 177.30 (9) C17—C11—C12—C13 59.98 (13)
C2—C1—C6—C5 3.41 (14) C10—C11—C12—C13 −59.96 (14)
C2—C1—C6—N1 −177.52 (9) C11—C12—C13—C14 −59.57 (12)
C7—N1—C6—C5 88.15 (11) C11—C12—C13—C18 60.37 (13)
C8—N1—C6—C5 −88.12 (12) C12—C13—C14—C15 59.55 (12)
C7—N1—C6—C1 −90.93 (11) C18—C13—C14—C15 −60.70 (14)
C8—N1—C6—C1 92.80 (11) C13—C14—C15—C17 −59.99 (13)
N2—N3—C7—N1 −0.81 (10) C13—C14—C15—C16 60.67 (14)
N2—N3—C7—S1 178.68 (7) C14—C15—C16—C9 −60.06 (15)
C8—N1—C7—N3 1.15 (9) C17—C15—C16—C9 60.65 (14)
C6—N1—C7—N3 −175.82 (8) C8—C9—C16—C15 −178.05 (10)
C8—N1—C7—S1 −178.34 (7) C10—C9—C16—C15 −59.33 (13)
C6—N1—C7—S1 4.69 (12) C18—C9—C16—C15 58.94 (13)
N3—N2—C8—N1 0.64 (10) C12—C11—C17—C15 −59.90 (12)
N3—N2—C8—C9 −178.62 (8) C10—C11—C17—C15 60.27 (13)
C7—N1—C8—N2 −1.17 (10) C14—C15—C17—C11 60.10 (13)
C6—N1—C8—N2 175.53 (9) C16—C15—C17—C11 −60.52 (13)
C7—N1—C8—C9 178.05 (8) C12—C13—C18—C9 −59.95 (12)
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C6—N1—C8—C9 −5.25 (15) C14—C13—C18—C9 60.26 (13)
N2—C8—C9—C16 122.54 (11) C8—C9—C18—C13 178.01 (9)
N1—C8—C9—C16 −56.58 (13) C16—C9—C18—C13 −59.20 (12)
N2—C8—C9—C10 3.91 (13) C10—C9—C18—C13 58.56 (12)
Hydrogen-bond geometry (Å, º) 
Cg2 is the centroid of the C1–C6 phenyl ring.
D—H···A D—H H···A D···A D—H···A
N3—H1N3···S1i 0.92 (2) 2.46 (2) 3.3253 (9) 158.4 (19)
C13—H13A···Cg2ii 0.98 2.97 3.8881 (13) 156
Symmetry codes: (i) −x+1/2, −y+3/2, z−1/2; (ii) y−1, −x+1, −z+1.
